Keywords: Polychlorinated biphenyls; Signalling disruption; Secondary necrosis; Casein kinase 2; AKT; Serine/Threonine kinase 1; CAR; Constitutive androstane receptor; CASP3; Caspase-3; CD; Control diet; CD+; Control diet + Aroclor 1260 exposure; CDK; Cyclin depend
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: NAFLD; NASH; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Traditional Korean medicine;
Keywords: Arterial stiffness; CAVI; Controlled attenuation parameter; Fibroscan; NAFLD;
Keywords: Diabetes; Glucagon; Hyperglucagonemia; NAFLD;
Keywords: Proton density fat fraction; MR elastography; hepatic steatosis; hepatic fibrosis liver stiffness; progression; pediatric NAFLD; ALT; Alanine aminotransferase; BMI; Body mass index; CyNCh; Cysteamine bitartrate delayed release for the treatment of nonalco
Keywords: Folic acid; NAFLD; Liver biopsy; Proton magnetic resonance spectroscopy;
Keywords: Silybum marianum oil; NAFLD; Hepatic steatosis; Oxidative stress;
Keywords: intrauterine programming; liver fat; adolescent health; metabolic determinants; gestational diabetes mellitus; ALSPAC; Avon Longitudinal Study of Parents and Children; EPOCH; Exploring Perinatal Outcomes in Children; GDM; Gestational diabetes mellitus; HF
Keywords: ALP; alkaline phosphatase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; BMI; body mass index; HOMA-IR; homeostatic model assessment insulin resistance; GGT; Gamma glutamyl transpeptidase; HDL-C; high density lipoprotein cholesterol; INR
Keywords: ALT; alanine aminotransferase; DILI; drug-induced liver injury; HBV; hepatitis B virus; HCV; hepatitis C virus; HDL; high-density lipoprotein; LDL; low-density lipoprotein; NAFLD; nonalcoholic fatty liver disease; NASH; nonalcoholic steatohepatitis; OCA;
Keywords: NAFLD; Bariatric surgery; Type 2 diabetes; Obesity;
Keywords: Fructose; Estrogen; Hepatic steatosis; Menopause; Steatohepatitis; αSMA; alpha smooth muscle actin; ALT; alanine aminotransferase; AST; aspartate aminotransferase; hCLS; hepatic crown-like structure; HFD; high fat diet; MCP-1; monocyte chemoattractant pr
Keywords: Irinotecan; Diet; NAFLD; Diarrhea; Steatosis; SN-38; Lard;
Keywords: ACC; acetyl-CoA carboxylase; ADPH; adipophilin; Akt/PKB; protein kinase B; ALOX5; arachidonate 5-lipoxygenase; BTN1A1; butyrophilin subfamily 1 member a1; CIDEA; cell death-inducing DNA fragmentation factor α-like effector A; COX2; cyclooxygenase 2; DGAT
Keywords: AGEs; advanced glycation end products; CEL; Nε-(carboxyethyl) lysine; CMA; NÏ-(carboxymethyl) arginine; CML; Nε-(carboxymethyl) lysine; H2O2; hydrogen peroxide; HCC; hepato-cellular carcinoma-; HMGB1; high mobility group box-1; NAFLD; nonalcoholic fatt
Keywords: Extracellular vesicles; Exosomes; Liver; NAFLD; NASH; HCC;
Keywords: NAFLD; nonalcoholic fatty liver disease; NASH; nonalcoholic steatohepatitis; FC; free cholesterol; VLDL; very low density lipoprotein; LDL; low density lipoprotein; mTOR; mechanistic target of rapamycin signaling; AMPK; AMP-activated protein kinase; TG; t
Keywords: BMI; body mass index; DTNB; dithio-bis-2-nitrobenzoic acid; HDL; high-density lipoproteins; HOMA-IR; homeostatic model assessment-insulin resistance index; ICP-MS; inductively coupled plasma mass spectrometry; MetS; metabolic syndrome; NAFLD; non-alcoholi
Keywords: Microbiota; Fructose; Inflammation; Wheat bran; Enterobacteriaceae; AMP; Antimicrobial peptides; AX; Arabinoxylan; CD; Clusters of differentiation; IFN-γ; Interferon gamma; IL; Interleukin; LPS; Lipopolysaccharides; MCP1; Monocyte chemotactic protein 1;
Keywords: Flavonoid; Gastrointestinal tract; Intestinal permeability; Incretins; Endotoxemia; Microbiota; CRC; colorectal cancer; DPP-IV; dipeptidyl peptidase IV; EC; (â)-epicatechin; EGCG; (â)-epigallocatechin gallate; GLP-1; glucagon-like peptide-1; GLP-2; gl
Keywords: Non-alcoholic fatty liver disease; NAFLD; NASH; Lipid; Sphingolipids; Ceramide; Sphingosine-1-phosphate; Lipidomics; Metabolic syndrome;
Keywords: Cardiovascular diesease; Dipeptidyl peptidase 4 inhibitor; Atherosclerosis; Heart failure; Myocardial infarction; AMI; acute myocardial infarction; BNP; Brain natriuretic peptide; CD26; cluster of differentiation 26; CHD; coronary heart disease; CKD; chro
Keywords: hypoxia; NASH; sleep apnea; CPAP; reactive oxygen species; F(2)-isoprostanes; AHI; Apnea/hypopnea index; ALT; Alanine aminotransferase; AST; Aspartate aminotransferase; BMI; Body mass index; CPAP; Continuous positive airway pressure; CRP; C-reactive prote
Keywords: ALT; alanine aminotransferase; NAFLD; nonalcoholic fatty liver disease; NHANES; National Health and Nutrition Examination Survey;
Keywords: ADA; adenosine deaminase; ADP; adenosine diphosphate; AMP; adenosine monophosphate; NAFLD; nonalcoholic fatty liver disease;
Keywords: PTP1B; protein tyrosine phosphatase 1B; CNS; central nervous system; HFD; high fat diet; NPY; neuropeptide Y; AMPK; 5' AMP-activated protein kinase; BAT; brown adipose tissue; AF; albiflorin; hAMSCs; human adipose tissue-derived mesenchymal stem cells; PP
Keywords: ACAT; acyl-coenzyme A:cholesterol acyltransferases; BSH; bile salt hydrolase; CFU; colony-forming unit; FAS; fatty acid synthase; FXR; farnesoid X receptor; GA; gum Arabic; GLP; glucagon-like peptides; HDL-C; high density lipoproteins cholesterol; HFD; hi
Keywords: NAFLD; NASH; Pediatric; Steatohepatitis; Fatty liver disease;
Keywords: NAFLD; non-alcoholic fatty liver disease; NAFL; non-alcoholic fatty liver; NASH; non-alcoholic steatohepatitis; mtDNA; mitochondrial DNA; FFAs; free fatty acids; TNF; tumor necrosis factor; CTRL; control; HF; high-fat; HF+HCh; high-fat+high-cholesterol; 7
Keywords: NAFLD; NASH; FIB-4; APRI;
Keywords: Hepatic steatosis; fat quantification; proton density fat fraction (PDFF); hepatic siderosis; iron quantification; BMI; body mass index; CI; confidence interval; LIC; liver iron concentration; MRI; magnetic resonance imaging; NAFLD; nonalcoholic fatty liv
Keywords: NAFLD; NASH; Obeticholic acid; Elafibranor; Liraglutide; Cenicriviroc; Selonsertib;
Keywords: Metabolic syndrome; Diabetes mellitus; Obesity; Fatty liver disease; NAFLD;
Keywords: Thyroid hormone; Liver cancer; Tumor microenvironment; Liver fibrogenesis; ALT; alanine amino transferase; BBC; basal cell carcinoma; CCL4; carbontetrachloride; CD; choline-deficient; CDK2; cyclin-dependent kinase; CSC; cancer stem cell; DKK; dickkopf Wnt
Keywords: AHR; aryl hydrocarbon receptor; ALD; alcoholic liver disease; BAs; bile acids; CAR; constitutive androstane receptor; CARM1; coactivator associated arginine methyltransferases 1; CBP/P300; CREB-binding protein/p300; CYP27A1/Cyp27a1; sterol 27α-hydroxylas
Keywords: NAFLD; NASH; Treatment; Pharmacotherapy;
Keywords: ALT; alanine aminotransferase; BMI; body mass index; CDC; Centers for Disease Control and Prevention; CI; confidence interval; EtFOSAA; 2-(N-ethyl-perfluorooctane sulfonamido) acetate; GAM; generalized additive models; GFR; glomerular filtration rate; HDL
Keywords: Iron; Ferroportin; Adipose Tissue; Nonalcoholic Fatty Liver Disease; AAS; atomic absorption spectroscopy; Adipoq; adiponectin; ANOVA; analysis of variance; AUC; area under the curve; bp; base pair; cDNA; complementary DNA; EFP; epididymal fat pad; FKO; fe
Keywords: ATP; Adenosine 5c-triphosphate; ALT; Alanine aminotransferase; aa; Amino acid; ASK1; Apoptosis signal- regulating kinase 1; AST; Aspartate aminotransferase; BASH; Both alcoholic and non-alcoholic liver disease; CCR2/CCR5; C-C chemokine receptor types 2 an
Keywords: Bioactive compounds; Jaboticaba; Obesity; Diabetes; Senescence; Functional food; AG; aged experimental group; CAT; catechin; COX-2; ciclooxygenase-2; Cyn-3-glu; cyanidin-3-glycoside; GAE; gallic acid equivalent; ESI; electrospray ionization; FRAP; ferric
Keywords: 8-OHdG; 8-hydroxy-2-deoxyguanosine; Îym; mitochondrial membrane potential; AMPK; AMP-activated protein kinase; apoB; apolipoprotein B; AST; aspartate transaminase; ALT; alanine transaminase; ATP; adenosine triphosphate; CPT-1; carnitine palmitoyl-transfe
Keywords: AGP; α1-acid glycoprotein; APP; acute phase protein; ATP; adenosine triphosphate; BHB; β-hydroxybutyrate; CoA; Coenzyme A; DIM; days in milk; GPC; glycerophosphocholine; NADP; nicotinamide adenine dinucleotide phosphate; NAFLD; non-alcoholic fatty liver
Keywords: Macrophages; Lipid metabolism; NAFLD; PAP; Atherosclerosis; AMD;
Keywords: AAD; antibiotic-associated diarrhoea; CDAD; C. difficile-associated diarrhoea; CFU; colony forming unit; FMT; faecal microbial transplantation; HE; hepatic encephalopathy; hs-CRP; high sensitive C-reactive protein; IBS; irritable bowel syndrome; IBS-SSS;
Keywords: ASL; arterial spin labeling; BMI; body mass index; BOLD; blood oxygen level-dependent; BP; blood pressure; CAD; coronary artery disease; CIMT; carotid intima-media thickness; CT; computed tomography; D; dimensional; DCE; dynamic contrast-enhanced; DTI; di
Keywords: NAFLD; NASH; Risk factors; Genetics;
Keywords: Nucleoskeleton; Envelopathies; Progeria; Myopathy; Neuropathy; Lipodystrophy; Nonalcoholic Fatty Liver Disease; BANF1; barrier to autointegration factor; EDMD; Emery-Dreifuss muscular dystrophy; FTI; farnesyl transferase inhibitor; FPLD2; type 2 (Dunnigan
Keywords: NASH; NAFLD; HCV; HBV; ROS; AFLD; alcoholic fatty liver disease; AMPK; adenosine monophosate-activated protein kinase; ASH; alcoholic steatohepatitis; ASK1; mitogen-activated protein kinase kinase kinase 5; ATP; adenosine triphosphate; CoA; coenzyme A;
Keywords: Steatosis; Risk Factor; Biomarker; NASH; BMI; body mass index; CI; confidence interval; IQR; interquartile range; MRI; magnetic resonance imaging; MRI-PDFF; magnetic resonance imaging-proton density fat fraction; NAFLD; nonalcoholic fatty liver disease;
Keywords: AGEs; advanced glycation end-products; CAD; coronary artery disease; CRP C; reactive protein; CTGF; connective tissue growth factor; DAG; diacyl glycerol; DCM; diabetic cardio-myopathy; DFU; diabetic foot ulcer; eNOS; endothelial nitric oxide synthase; FO